StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences Arcus total other collaboration revenue by Quarter

Arcus total other collaboration revenue ($M) ($M)

QuarterlyAnnual

Gilead Sciences Arcus total other collaboration revenue: $25M in Q2 2026, up 212.5% from a year earlier. That is the highest of the 14 quarters on record here.

Latest, Q2 2026
25
Period ended Jun 30, 2026
Change on a year earlier
+212.5%
8 in Q2 2025
History
14 quarters
Since Q1 2023
Sources
9
Documents cited below

Where the Q2 2026 figure comes from

Source: Arcus Biosciences (RCUS) Form 10-Q (filed 2026-08-05) ↗

Reported in Arcus Biosciences (RCUS) Form 10-Q / 10-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedArcus total other collaboration revenue ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202625+212.5%Arcus Biosciences (RCUS) Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 20265-37.5%Arcus Biosciences (RCUS) Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 20254-50.0%Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗
Q3 2025Sep 30, 20256-14.3%Arcus Biosciences (RCUS) Form 10-Q (filed 2025-10-28) ↗
Q2 2025Jun 30, 20258-27.3%Arcus Biosciences (RCUS) Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 20258-20.0%Arcus Biosciences (RCUS) Form 10-Q (filed 2026-05-05) ↗
Q4 2024Dec 31, 20248-11.1%Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗
Q3 2024Sep 30, 20247-30.0%Arcus Biosciences (RCUS) Form 10-Q (filed 2025-10-28) ↗
Q2 2024Jun 30, 202411+10.0%Arcus Biosciences (RCUS) Form 10-Q (filed 2025-08-06) ↗
Q1 2024Mar 31, 202410+25.0%Arcus Biosciences (RCUS) Form 10-Q (filed 2025-05-06) ↗
Q4 2023Dec 31, 20239–Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗
Q3 2023Sep 30, 202310–Arcus Biosciences (RCUS) Form 10-Q (filed 2024-11-06) ↗
Q2 2023Jun 30, 202310–Arcus Biosciences (RCUS) Form 10-Q (filed 2024-08-08) ↗
Q1 2023Mar 31, 20238–Arcus Biosciences (RCUS) Form 10-Q (filed 2024-05-08) ↗

Cite this data

StockData. (2026). Gilead Sciences Arcus total other collaboration revenue ($M), quarterly Q1 2023–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/rcus-rev-other-collab

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.